For help on how to get the results you want, see our search tips.
108 results
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Zoloft
sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009 -
List item
Referral: Tazocin
piperacillin, tazobactam, associated names: Tazobac, Tazocel, Tazonam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/02/2011, Last updated: 19/11/2013 -
List item
Referral: Renitec
enalapril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, EC decision date: 21/05/2003, Last updated: 02/12/2003 -
List item
Referral: Calcichew D3 mite
calcium, colecalciferol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Diovan Comp
valsartan, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009 -
List item
Referral: Haldol and associated names
haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011 -
List item
Referral: Etopophos
etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Sandostatin LAR and associated names
ocreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014 -
List item
Referral: Buflomedil
buflomedil, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 13/02/2012, Last updated: 13/06/2012 -
List item
Referral: Glucophage/Glucophage Forte/Risidon/Dianben
metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001 -
List item
Referral: Ecazide
captopril, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2002, EC decision date: 22/08/2002, Last updated: 19/09/2002 -
List item
Referral: Roaccutane
isotretinoin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2003, EC decision date: 17/10/2003, Last updated: 02/12/2003 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Referral: Tritace
ramipril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 24/04/2009 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Lopid
gemfibrozil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/03/2004, EC decision date: 29/07/2004, Last updated: 18/08/2004 -
List item
Referral: Ketoprofen topical
ketoprofen, associated names: Fastum, Ketum, Orudis, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 29/11/2010, Last updated: 28/10/2011 -
List item
Referral: Scandonest and associated names
mepivacaine, associated names: Biocaine, Scandicaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 02/08/2018, Last updated: 07/08/2018 -
List item
Referral: Daivobet
calcipotriol, betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Somatropin
somatropin, associated names: Genotropin, Humatrope, Maxomat, Norditropin, Saizen, Zomacton, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/12/2011, EC decision date: 27/02/2012, Last updated: 23/04/2012 -
List item
Referral: Atacand Plus
candesartan, hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Lipitor
atorvastatin, associated names: Atorvastatin, Atorvastatina Nostrum, Atorvastatina Parke-Davis, Atorvastatina Pharmacia, Cardyl, Edovin, Liprimar, Orbeos, Prevencor, Sortis, Tahor, Texzor, Torvast, Totalip, Xarator, Zarator, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 13/12/2010, Last updated: 10/04/2012 -
List item
Referral: Lamictal
lamotrigine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 23/07/2008, Last updated: 08/09/2008